TERRY THOMPSON: Open Payments
NPI 1205121498 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 34 payments from 14 companies in 2025. Trend: 2023 $813 · 2024 $1,563 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $210 |
| Boston Scientific Corporation | 1 | $75 |
| Novartis Pharmaceuticals Corporation | 4 | $73 |
| Amgen Inc. | 4 | $58 |
| Merck Sharp & Dohme LLC | 3 | $54 |
| SCPHARMACEUTICALS INC. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Medtronic, Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
Products named: VYNDAQEL, WATCHMAN FLX, LEQVIO, VYNDAMAX, REPATHA, FUROSCIX, FARXIGA, CAMZYOS.
Industry payments across ID — which companies pay providers there.
